SUBACUTE MASSIVE PULMONARY THROMBOEMBOLISM IN YOUNG PATIENTS: A COMPARATIVE PRESENTATION

Dušica Gujaničić; Nataša Benović; Stefan Nešović

doi:10.5937/sanamed0-48325

Dušica Gujaničić Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia
Nataša Benović Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia
Stefan Nešović Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia

DOI: https://doi.org/10.5937/sanamed0-48325

Keywords: pulmonary thromboembolism, subacute, massive, MSCTPA, risk factor, genetic, acquired, unidentified

Abstract

Introduction: Subacute massive pulmonary embolism is a potentially fatal condition that can manifest in various clinical ways in a young patient, from mild and nonspecific to lethal. The incidence of pulmonary embolism in the younger population should not be overlooked, whether it involves individuals with certain risk factors, either genetic or acquired, or individuals with unidentified risk factors.

Case Presentation: We are presenting two young patients, aged 35 and 37, who had a protracted course of disease and clinical manifestations at least 15 days before admission. The first patient had nonspecific pains and sensations in the chest area and coughed up blood on two occasions. The day before admission, he had an intense one-hour swimming workout. The second patient had rapid fatigue and choking, which led to an echocardiogram of the heart and a treadmill test that was terminated at the second level due to poor condition, as stated by the patient himself. He came in due to intense pain in the epigastrium, preceded by a loss of consciousness. In both patients, a diagnosis of massive PTE was made: the first by Multi-Slice Computed Tomography of the pulmonary artery (MSCTPA) and the second by clinical autopsy. The first patient received thrombolytic therapy and was discharged with NOACs (Apixaban) after 10 days of hospitalization.

Conclusion: It is always necessary to keep in mind the possibility of PTE, even in younger patients and in cases with subtle clinical presentations, even without identified predisposing factors.

Author Biographies

Dušica Gujaničić, Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia

ORCID: 0009-0007-9226-0326

Nataša Benović , Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia

ORCID: 0009-0005-3794-5379

Stefan Nešović , Emergency Department, University Clinical Center of Serbia, Belgrade, Serbia

ORCID: 0009-0005-1215-2831

References

Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes García M, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995;2(3):227-9. doi: 10.1007/BF01062714.

Solanki NN, Tanwar N, Solanki ND. Subacute massive pulmonary embolism treated with Streptokinase. Cureus. 2020;12(10):e11157. doi: 10.7759/cureus.11157.

Iorio A, Kearon C, Filippucci E, Marcucci M, Macura A, Pengo V, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med. 2010;170(19):1710–6. doi:10.1001/archinternmed.2010.367.

Hewitt M, Devine C, Gonzalez L. Pulmonary embolism in young adults (18-45 years). Eur J Intern Med. 2018;54:e23-e24. doi: 10.1016/j.ejim.2018.05.035.

Sakuma M, Nakamura M, Takahashi T, Kitamukai O, Yazu T, Yamada N et al. Pulmonary embolism is an important cause of death in young adults. Circ J. 2007;71(11):1765-70. doi: 10.1253/circj.71.1765.

Belohlávek J., Dytrych V., Linhart A. Pulmonary embolism. Part I. Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis, and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–38.

Mohan B, Chhabra ST, Aslam N, Wander GS, Sood NK, Verma S, et al.Mechanical breakdown and thrombolysis in subacute massive pulmonary embolism: a prospective trial. World J Cardiol. 2013; 5(5): 141-7. doi: 10.4330/wjc.v5.i5.141.

Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A. Pulmonary embolism in young people. Hamostaseologie. 2014;34(1):88–92.doi: 10.5482/HAMO-13-05-0028.

Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost. 1997;78(1):1-6.

O. Parenti N, Berti A, Bonarelli S, Fanciulli A. Pulmonary embolism in younger adults: Clinical presentation and comparison of two scoring systems used to estimate pretest probability of disease in the emergency department. Ann Emerg Med. 2004;44(4):S36. doi:10.1016/j.annemergmed.2004.07.119.

Theilade J, Winkel BG, Holst AG, Tfelt-Hansen J, Svendsen JH, Haunso S. A nationwide, retrospective analysis of symptoms, comorbidities, medical care and autopsy findings in cases of fatal pulmonary embolism in younger patients. J Thromb Haemost. 2010;8(8):1723–9. doi: 10.1111/j.1538-7836.2010.03922.x.

Kukla P, Długopolski R, Krupa E, Furtak R, Mirek-Bryniarska E, et al. How often pulmonary embolism mimics acute coronary syndrome? Kardiol Pol. 2011;69(3):235-40.

ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med. 2004;164(15):1685-9. doi:10.1001/archinte.164.15.1685.

Kucher N, Printzen G, Goldhaber SZ Prognostic role of brain natriuretic peptide in acute pulmonary embolism.Circulation. 2003;107(20):2545-7. doi:10.1161/01.CIR.0000074039.45523.BE.

Meyer G, Tamisier D, Sors H, Stern M, Vouhe P, Makowski S, et al. Pulmonary embolectomy: a 20-year experience at one center. Ann Thorac Surg. 1991;51(2):232–6.doi: 10.1016/0003-4975(91)90792-o.

Hodkinson EC, Noad RL, Menown IB. Massive pulmonary embolus presenting with abdominal pain. Ulster Med J. 2012;81(2):98.

Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, et al Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354(22):2317-27. doi: 10.1056/NEJMoa052367.

Kline JA, Courtney DM, Kabrhel C, Moore CL, Smithline HA, Plewa MC, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772–80. doi: 10.1111/j.1538-7836.2008.02944.x.

Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–11. doi: 10.1056/NEJMoa1302097.

Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet.1999; 353(9162):1386–9.doi: 10.1016/s0140-6736(98)07534-5.

Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet. 1993;341(8844):507–11.doi: 10.1016/0140-6736(93)90274-k.

Braekkan SK, Siegerink B, Lijfering WM, Hansen JB, Cannegieter SC, Rosendaal FR. Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights. Semin Thromb Hemost. 2013;39(5):533-40. doi: 10.1055/s-0033-1343355.